ARCHIVES

In Brief: ACS Appoints Directors For Government Relations And Grassroots Development

This article is from The Cancer Letter archive.

Vol. 23 No. 16 | April 25, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Outside NIH, Applied Research Underfunded; Strong Federal Role Needed, Chabner Says

May 12, 1995

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

March 3, 1989

Revised Price Equivalent to Lower Dose of Avastin

November 8, 2012